Start for free

Manipal Health Enterprises Limited

NSE: MANIPALHOSHealthcare

Manipal Health Enterprises Limited Share Price & Analysis

₹725.20−0.11%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹725.20−0.11%
Open
₹729.00
High
₹738.00
Low
₹720.50
Close
₹725.20
52W High
₹815.00
52W Low
₹625.00
Volume
1177K
Lot Size
1
Sector
Healthcare
Market Cap
₹95K Cr
Face Value
₹2
Large Cap

Price Chart

Candle
Range

Fundamentals

P/E
108.00
Sector P/E
54.70
P/B
—
EPS
₹7.56
ROE
12.70%
ROCE
12.10%
D/E Ratio
1.53
Div Yield
0.00%
Book Value
—

Strengths

    Concerns

    • Premium to sector peers (P/E 108x vs industry 54.7x)
    • Elevated debt levels (D/E 1.5x)

    Peer Comparison

    CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
    SUNPHARMA
    Sun Pharmaceutical Industries Limited
    ₹1,899
    		₹4.6L Cr36.15.461620.50.07
    DIVISLAB
    Divi's Laboratories Limited
    ₹9,100
    		₹2.4L Cr81.114.4216.5220.01
    TORNTPHARM
    Torrent Pharmaceuticals Limited
    ₹4,857
    		₹1.8L Cr82.819.5827.415.20.33
    APOLLOHOSP
    Apollo Hospitals Enterprise Limited
    ₹8,650
    		₹1.2L Cr59.113.1321.217.40.88
    CIPLA
    Cipla Limited
    ₹1,385
    		₹1.1L Cr31.33.2511.615.50.01
    ZYDUSLIFE
    Zydus Lifesciences Limited
    ₹1,120
    		₹1.1L Cr234.1621.221.10.38
    LAURUSLABS
    Laurus Labs Limited
    ₹1,840
    		₹99K Cr90.918.7418.317.80.46

    Showing 7 peers in the same sector · Sorted by market cap

    Latest News

    All news

    Manipal Health reports unaudited Q1 FY27 results

    *Manipal Health reports unaudited Q1 FY27 results* per a newspaper publication filing. The company released its unaudited financial results for the quarter ended June 30, 2026. Key figures like revenue and net profit were not disclosed in the notice. Final audited results will be issued later per regulatory norms. 📊 *STOCKS:* $MANIPAL | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #Earnings

    NSE Filing21 Aug
    Low Impact

    Financials

    Quarterly Results

    MetricJun 2026Mar 2026Jun 2025
    Revenue
    ₹3.1K Cr
    7.3%
    ₹2.9K Cr
    28.8%
    ₹2.2K Cr
    Op. Profit
    ₹737 Cr
    6.7%
    ₹691 Cr
    17.9%
    ₹586 Cr
    OPM
    24.0%
    0.0%
    24.0%
    7.7%
    26.0%
    Net Profit
    ₹243 Cr
    29.9%
    ₹187 Cr
    26.4%
    ₹254 Cr
    EPS (₹)
    1.96
    29.8%
    1.51
    30.4%
    2.17

    Values in ₹ Cr · Source: Screener.in

    Annual Profit & Loss

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
    Revenue
    ₹10.3K Cr
    25.4%
    ₹8.2K Cr
    33.5%
    ₹6.2K Cr
    28.4%
    ₹4.8K Cr
    20.9%
    ₹4.0K Cr
    119.2%
    ₹1.8K Cr
    Expenses
    ₹7.7K Cr
    26.3%
    ₹6.1K Cr
    36.2%
    ₹4.5K Cr
    27.3%
    ₹3.5K Cr
    15.5%
    ₹3.1K Cr
    105.9%
    ₹1.5K Cr
    Op. Profit
    ₹2.6K Cr
    22.8%
    ₹2.1K Cr
    26.4%
    ₹1.7K Cr
    31.6%
    ₹1.3K Cr
    38.9%
    ₹921 Cr
    179.1%
    ₹330 Cr
    OPM
    25.0%
    3.8%
    26.0%
    3.7%
    27.0%
    0.0%
    27.0%
    17.4%
    23.0%
    27.8%
    18.0%
    Other Income
    ₹111 Cr
    17.2%
    ₹134 Cr
    255.8%
    ₹-86 Cr
    79.2%
    ₹-48 Cr
    116.4%
    ₹293 Cr
    723.4%
    ₹-47 Cr
    Interest
    ₹864 Cr
    68.8%
    ₹512 Cr
    12.5%
    ₹455 Cr
    38.3%
    ₹329 Cr
    0.9%
    ₹326 Cr
    59.0%
    ₹205 Cr
    Depreciation
    ₹680 Cr
    34.1%
    ₹507 Cr
    27.7%
    ₹397 Cr
    26.0%
    ₹315 Cr
    23.0%
    ₹256 Cr
    39.9%
    ₹183 Cr
    PBT
    ₹1.2K Cr
    5.2%
    ₹1.2K Cr
    66.7%
    ₹745 Cr
    27.1%
    ₹586 Cr
    7.3%
    ₹632 Cr
    701.9%
    ₹-105 Cr
    Tax %
    22.0%
    69.2%
    13.0%
    53.6%
    28.0%
    3.7%
    27.0%
    92.9%
    14.0%
    53.3%
    30.0%
    Net Profit
    ₹917 Cr
    15.2%
    ₹1.1K Cr
    103.0%
    ₹533 Cr
    24.2%
    ₹429 Cr
    20.8%
    ₹542 Cr
    492.8%
    ₹-138 Cr
    EPS (₹)
    7.56
    72.7%
    27.65
    60.8%
    70.5
    24.3%
    56.73
    20.8%
    71.63
    456.0%
    -20.12
    Div Payout
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%
    0.0%

    Values in ₹ Cr · Source: Screener.in

    Balance Sheet

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
    Liabilities
    Equity Capital
    ₹236 Cr
    206.5%
    ₹77 Cr
    1.3%
    ₹76 Cr
    0.0%
    ₹76 Cr
    0.0%
    ₹76 Cr
    10.1%
    ₹69 Cr
    Reserves
    ₹8.2K Cr
    41.9%
    ₹5.8K Cr
    46.4%
    ₹3.9K Cr
    24.4%
    ₹3.2K Cr
    15.9%
    ₹2.7K Cr
    156.8%
    ₹1.1K Cr
    Borrowings
    ₹12.9K Cr
    101.5%
    ₹6.4K Cr
    24.5%
    ₹5.1K Cr
    134.9%
    ₹2.2K Cr
    8.3%
    ₹2.0K Cr
    28.1%
    ₹1.6K Cr
    Other Liabilities
    ₹3.4K Cr
    107.8%
    ₹1.7K Cr
    2.9%
    ₹1.6K Cr
    31.0%
    ₹2.3K Cr
    7.3%
    ₹2.5K Cr
    91.6%
    ₹1.3K Cr
    Total Liabilities
    ₹24.7K Cr
    78.1%
    ₹13.9K Cr
    29.1%
    ₹10.8K Cr
    38.6%
    ₹7.8K Cr
    5.7%
    ₹7.3K Cr
    82.6%
    ₹4.0K Cr
    Assets
    Fixed Assets
    ₹18.8K Cr
    90.9%
    ₹9.8K Cr
    41.7%
    ₹6.9K Cr
    44.9%
    ₹4.8K Cr
    4.4%
    ₹4.6K Cr
    101.1%
    ₹2.3K Cr
    CWIP
    ₹795 Cr
    29.5%
    ₹614 Cr
    51.5%
    ₹1.3K Cr
    22.6%
    ₹1.0K Cr
    5.1%
    ₹1.1K Cr
    164.3%
    ₹412 Cr
    Investments
    ₹2.7K Cr
    50.6%
    ₹1.8K Cr
    58.4%
    ₹1.1K Cr
    8.0%
    ₹1.0K Cr
    35.2%
    ₹768 Cr
    39.4%
    ₹551 Cr
    Other Assets
    ₹2.5K Cr
    49.9%
    ₹1.7K Cr
    16.6%
    ₹1.4K Cr
    58.1%
    ₹908 Cr
    0.1%
    ₹907 Cr
    15.7%
    ₹784 Cr
    Total Assets
    ₹24.7K Cr
    78.1%
    ₹13.9K Cr
    29.1%
    ₹10.8K Cr
    38.6%
    ₹7.8K Cr
    5.7%
    ₹7.3K Cr
    82.6%
    ₹4.0K Cr

    Values in ₹ Cr · Source: Screener.in

    Cash Flow Statement

    ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
    Operating CF
    ₹2.1K Cr
    32.4%
    ₹1.6K Cr
    13.0%
    ₹1.4K Cr
    20.9%
    ₹1.1K Cr
    42.7%
    ₹805 Cr
    89.0%
    ₹426 Cr
    Investing CF
    ₹-7.0K Cr
    176.1%
    ₹-2.5K Cr
    192.4%
    ₹-870 Cr
    12.5%
    ₹-994 Cr
    41.9%
    ₹-1.7K Cr
    810.1%
    ₹-188 Cr
    Financing CF
    ₹5.0K Cr
    448.0%
    ₹904 Cr
    461.6%
    ₹-250 Cr
    73.6%
    ₹-144 Cr
    115.3%
    ₹941 Cr
    436.1%
    ₹-280 Cr
    Net Cash Flow
    ₹8 Cr
    111.4%
    ₹-70 Cr
    126.1%
    ₹268 Cr
    2133.3%
    ₹12 Cr
    64.7%
    ₹34 Cr
    181.0%
    ₹-42 Cr
    Free Cash Flow
    ₹767 Cr
    47.5%
    ₹520 Cr
    62.7%
    ₹1.4K Cr
    69.4%
    ₹823 Cr
    30.8%
    ₹629 Cr
    88.3%
    ₹334 Cr

    Values in ₹ Cr · Source: Screener.in

    Key Ratios History

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
    Debtor Days
    33d
    17.9%
    28d
    3.7%
    27d
    12.5%
    24d
    11.1%
    27d
    3.8%
    26d
    Inventory Days
    29d
    0.0%
    29d
    3.3%
    30d
    30.4%
    23d
    17.9%
    28d
    40.0%
    20d
    Days Payable
    253d
    3.3%
    245d
    25.8%
    330d
    16.6%
    283d
    15.0%
    246d
    33.7%
    371d
    Cash Conv. Cycle
    -190d
    1.1%
    -188d
    31.1%
    -273d
    15.7%
    -236d
    24.2%
    -190d
    41.5%
    -325d
    Working Capital Days
    -70d
    75.0%
    -40d
    32.2%
    -59d
    5.4%
    -56d
    50.4%
    -113d
    18.9%
    -95d
    ROCE
    12.0%
    25.0%
    16.0%
    15.8%
    19.0%
    0.0%
    19.0%
    5.6%
    18.0%
    —

    Source: Screener.in · Lower days = better efficiency

    Related Analysis

    Same Sector

    ALKEMAlkem Laboratories LimitedNeutralAPOLLOHOSPApollo Hospitals Enterprise LimitedNeutralAUROPHARMAAurobindo Pharma LimitedNeutralBIOCONBiocon LimitedNeutralCIPLACipla LimitedNeutral

    Frequently Asked Questions

    What is Manipal Health Enterprises Limited share price today?
    Manipal Health Enterprises Limited (MANIPALHOS) is currently trading at ₹725.2 on NSE, down 0.11% as of the last market session. Prices update daily after market close on MarketNetra.
    Is Manipal Health Enterprises Limited available in F&O (Futures & Options)?
    Yes, Manipal Health Enterprises Limited (MANIPALHOS) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
    What is Manipal Health Enterprises Limited 52-week high and low?
    Manipal Health Enterprises Limited's 52-week high is ₹815 and the 52-week low is ₹625. The current price of ₹725.2 is 11.0% below the 52W high.
    What is Manipal Health Enterprises Limited P/E ratio?
    Manipal Health Enterprises Limited's current P/E ratio is 108. This indicates the market is paying ₹108 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
    How to trade Manipal Health Enterprises Limited options?
    Manipal Health Enterprises Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade MANIPALHOS options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.